DE69909068D1 - Substituierte bisindolylmaleimide zur inhibierung der zellproliferation - Google Patents

Substituierte bisindolylmaleimide zur inhibierung der zellproliferation

Info

Publication number
DE69909068D1
DE69909068D1 DE69909068T DE69909068T DE69909068D1 DE 69909068 D1 DE69909068 D1 DE 69909068D1 DE 69909068 T DE69909068 T DE 69909068T DE 69909068 T DE69909068 T DE 69909068T DE 69909068 D1 DE69909068 D1 DE 69909068D1
Authority
DE
Germany
Prior art keywords
cell proliferation
inhibiting cell
bisindolylmaleimides
substituted
substituted bisindolylmaleimides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69909068T
Other languages
English (en)
Other versions
DE69909068T2 (de
Inventor
Hooda Dhingra
Mary Huryn
June Ke
Federico Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69909068D1 publication Critical patent/DE69909068D1/de
Application granted granted Critical
Publication of DE69909068T2 publication Critical patent/DE69909068T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69909068T 1998-03-17 1999-03-10 Substituierte bisindolylmaleimide zur inhibierung der zellproliferation Expired - Lifetime DE69909068T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7833198P 1998-03-17 1998-03-17
US78331P 1998-03-17
PCT/EP1999/001534 WO1999047518A1 (en) 1998-03-17 1999-03-10 Substituted bisindolymaleimides for the inhibition of cell proliferation

Publications (2)

Publication Number Publication Date
DE69909068D1 true DE69909068D1 (de) 2003-07-31
DE69909068T2 DE69909068T2 (de) 2004-05-06

Family

ID=22143350

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69909068T Expired - Lifetime DE69909068T2 (de) 1998-03-17 1999-03-10 Substituierte bisindolylmaleimide zur inhibierung der zellproliferation

Country Status (34)

Country Link
US (1) US6048887A (de)
EP (1) EP1064279B1 (de)
JP (2) JP5026633B2 (de)
KR (1) KR100659411B1 (de)
CN (1) CN1127500C (de)
AR (1) AR018162A1 (de)
AT (1) ATE243693T1 (de)
AU (1) AU755673B2 (de)
BR (1) BR9908882A (de)
CA (1) CA2322689C (de)
CO (1) CO5070675A1 (de)
CZ (1) CZ299068B6 (de)
DE (1) DE69909068T2 (de)
DK (1) DK1064279T3 (de)
ES (1) ES2203111T3 (de)
HK (1) HK1036452A1 (de)
HR (1) HRP20000585B1 (de)
HU (1) HU228831B1 (de)
ID (1) ID26353A (de)
IL (1) IL138247A (de)
MA (1) MA26613A1 (de)
MY (1) MY121046A (de)
NO (1) NO320306B1 (de)
NZ (1) NZ506476A (de)
PE (1) PE20000340A1 (de)
PL (1) PL195323B1 (de)
PT (1) PT1064279E (de)
RS (1) RS49965B (de)
RU (1) RU2208612C2 (de)
SA (1) SA99191295B1 (de)
TR (1) TR200002580T2 (de)
TW (1) TW539676B (de)
WO (1) WO1999047518A1 (de)
ZA (1) ZA992072B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1064279E (pt) * 1998-03-17 2003-10-31 Hoffmann La Roche Bisindolilmaleimidas substituidas para a inibicao da proliferacao celular
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
BR0014680A (pt) * 1999-10-12 2002-06-11 Hoffmann La Roche Pirróis substituìdos como agentes antiproliferativos para o tratamento de câncer
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
US6469179B1 (en) 2000-10-03 2002-10-22 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6482847B2 (en) 2000-10-03 2002-11-19 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6548531B2 (en) 2001-02-09 2003-04-15 Hoffmann-La Roche Inc. Method for cancer therapy
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
WO2008117935A1 (en) * 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same
CN102924437B (zh) * 2012-11-19 2014-07-02 东华大学 3-哌嗪基-4-吲哚马来酰亚胺化合物及其制备和应用
WO2019000224A1 (zh) * 2017-06-27 2019-01-03 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DK0817627T3 (da) * 1993-12-23 2005-06-06 Lilly Co Eli Inhibitorer af proteinkinase C
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PT1064279E (pt) * 1998-03-17 2003-10-31 Hoffmann La Roche Bisindolilmaleimidas substituidas para a inibicao da proliferacao celular

Also Published As

Publication number Publication date
IL138247A0 (en) 2001-10-31
ZA992072B (en) 1999-09-22
BR9908882A (pt) 2000-11-21
YU55200A (sh) 2002-11-15
JP2010222366A (ja) 2010-10-07
CN1127500C (zh) 2003-11-12
KR100659411B1 (ko) 2006-12-18
PL195323B1 (pl) 2007-09-28
JP2002506864A (ja) 2002-03-05
RU2208612C2 (ru) 2003-07-20
HRP20000585B1 (en) 2009-02-28
PT1064279E (pt) 2003-10-31
WO1999047518A1 (en) 1999-09-23
HRP20000585A2 (en) 2001-08-31
HUP0101258A3 (en) 2002-08-28
HU228831B1 (en) 2013-05-28
AU3409999A (en) 1999-10-11
AU755673B2 (en) 2002-12-19
US6048887A (en) 2000-04-11
CO5070675A1 (es) 2001-08-28
TW539676B (en) 2003-07-01
NZ506476A (en) 2003-12-19
TR200002580T2 (tr) 2000-11-21
NO20004579L (no) 2000-09-14
ES2203111T3 (es) 2004-04-01
CA2322689C (en) 2008-11-25
PE20000340A1 (es) 2000-05-13
ID26353A (id) 2000-12-14
CA2322689A1 (en) 1999-09-23
HK1036452A1 (en) 2002-01-04
NO20004579D0 (no) 2000-09-14
EP1064279A1 (de) 2001-01-03
HUP0101258A2 (hu) 2001-10-28
RS49965B (sr) 2008-09-29
MA26613A1 (fr) 2004-12-20
CN1293671A (zh) 2001-05-02
MY121046A (en) 2005-12-30
IL138247A (en) 2005-08-31
PL342964A1 (en) 2001-07-16
KR20010041995A (ko) 2001-05-25
EP1064279B1 (de) 2003-06-25
CZ299068B6 (cs) 2008-04-16
ATE243693T1 (de) 2003-07-15
NO320306B1 (no) 2005-11-21
CZ20003384A3 (cs) 2000-12-13
SA99191295B1 (ar) 2006-04-26
AR018162A1 (es) 2001-10-31
DE69909068T2 (de) 2004-05-06
JP5026633B2 (ja) 2012-09-12
DK1064279T3 (da) 2003-10-06

Similar Documents

Publication Publication Date Title
DE69722003D1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
DE69715870D1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
PT1114051E (pt) Inibidores de p38
DE69932397D1 (de) Zusammensetzung zur äusserlichen verwendung
ATE318603T1 (de) Pyrrolotriazin kinasehemmer
DE69936997D1 (de) Paletteneinrichtung
EE200000610A (et) p38 heterotsüklilised inhibiitorid
DE69909068D1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
DE59905573D1 (de) Polsterträger
DK1181269T3 (da) Celleproliferationsinhibitorer
NO990113D0 (no) Flerskrog-fart°y
NO992198D0 (no) R°rledningspigg
ID29128A (id) Gen untuk biosintesis epotilon
DE69737060D1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
DE69907647D1 (de) Plattenschieber
DE50003775D1 (de) Schaltungsanordnung zur direktmodulation
DE60023182D1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
EP1135126A4 (de) Myt1 kinase inhibitoren
DE59709331D1 (de) Schaltungsanordnung zur Offset-Kompensation
PT1121349E (pt) Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta
PT1077945E (pt) Isoquinolinas como inibidores de uroquinase
FI4094U1 (fi) Jakokaappi
ID23842A (id) Pelat untuk perangkat distribusi
NO983018D0 (no) R°ranordning

Legal Events

Date Code Title Description
8364 No opposition during term of opposition